Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Simplified Frailty Index & Memorial Sloan Kettering Frailty Index classify partially overlapping but distinct RRMM pts getting CAR T; binary SFI not assoc w/ efficacy/safety, continuous MSK-FI independently assoc w/ PFS.”
Title: Beyond binary: graded frailty assessment and outcomes after CAR-T cell therapy in relapsed/refractory multiple myeloma
Authors: H. Hashmi, Kevin Han, T. McCready, A. Tin, S. Rajeeve, G. Shah, H. Landau, M. Scordo, S. Giralt, A. Lesokhin, M. Merz, E. Jurgens, S. Mailankody, S. Z. Usmani, Armin Shahrokni
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily
